3T Devices –The focus of a New FDA Safety Communication

On October 19, 2018, the FDA issued a Safety Communication providing additional information to protect susceptible patients from the risk of infection. Wright & Schulte currently represents injured individuals and families irreparably damaged from mycobacterium chimaera infections while undergoing open-heart surgery. Symptoms of infection include: Hearing loss Diminished eye sight Fever Malaise Weight loss Coughing Dyspnea [...]